SEP 23, 2021 5:10 AM PDT

Houses on Mars Held Together With Astronaut Blood?!

WRITTEN BY: Tara Fernandez

A protein abundantly present in the blood plasma of astronauts is perfect for building shelters in outer space, say researchers at the University of Manchester. In the future, space voyagers can mix their bodily fluids with extraterrestrial soil to form a biocomposite material with compressive strengths comparable to concrete.

One of the most significant challenges with establishing life on Mars is the cost—ferrying a single brick from Earth to Mars costs over $2 million. As a result, scientists have taken an out-of-the-box approach to developing cost-effective building materials for shelters and other structures for new arrivals on the Red Planet. The ideal components would be materials that future space crews would already have access to when they arrive.

In a study published in Materials Today Bio, a team of researchers describes AstroCrete, a strong, concrete-like substance made by mixing dust with human serum albumin. This blood protein, produced by the liver, shuttles vitamins, enzymes, and other essential substances around the body. The addition of urea (a metabolic waste product excreted in tears, urine, and sweat) makes AstroCrete 300 percent more robust, giving it about twice the compressive strength of earthly concrete.

This impressive durability results from a chemical reaction that occurs when blood proteins denature outside the body, forming structural bonds known as "beta sheets" which are capable of holding materials together at a molecular level.

AstroCrete is a novel solution to a long-standing interplanetary travel problem, says Aled Roberts, a lead researcher from the University of Manchester. The team's novel technology could pave the way for future construction projects on distant planets. According to Roberts' calculations, a crew of six astronauts could produce more than 500 kilograms of AstroCrete over two years—which could hold sandbags containing Martian soil together to form housing pods. In addition, this so-called biocomposite can also potentially be 3D-printed into more intricate structures.

Interestingly, the use of blood in architecture is far from a new concept. As early as medieval times, animal blood was used as a binder for mortar. "It is exciting that a major challenge of the space age may have found its solution based on inspirations from medieval technology," said Roberts.

 


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 15, 2021
Immunology
Your Immune System Can't Deal With All the Plastic You're Eating
JUL 15, 2021
Your Immune System Can't Deal With All the Plastic You're Eating
Microplastics—tiny fragments of plastic, less than five millimeters in diameter—pollute our environment and, ...
AUG 05, 2021
Technology
Top Ways to Make the Most out of Your Ethernet
AUG 05, 2021
Top Ways to Make the Most out of Your Ethernet
Today, the Ethernet connection has emerged as one of the most popular ways to make the most out of an internet connectio ...
AUG 10, 2021
Immunology
An Immune Molecule Helps Create 'Good' Fat
AUG 10, 2021
An Immune Molecule Helps Create 'Good' Fat
Not all fat is ‘bad’—there’s white fat that builds up when excess calories are consumed. But, th ...
AUG 16, 2021
Coronavirus
Why is the Delta variant causing more infections?
AUG 16, 2021
Why is the Delta variant causing more infections?
New research suggests that the Delta variant is more infectious than the original COVID-19 virus.
OCT 04, 2021
Cancer
Predicting Progression-Free Survival in a Melanoma Study
OCT 04, 2021
Predicting Progression-Free Survival in a Melanoma Study
IsoPlexis’ Single-Cell Proteomics Predict Progression-Free Survival in Melanoma Study While advancements in oncolo ...
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
Loading Comments...